Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2014)

Anavex Life Sciences (AVXL) has 3 years of Total Non-Current Liabilities data on file, last reported at $1.9 million in Q2 2014.

• For the quarter ending Q2 2014, Total Non-Current Liabilities changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2014 stood at $1.9 million (changed N/A YoY), and the FY2013 full-year result was $2.0 million, down 32.39% from the prior year.
• Total Non-Current Liabilities advanced to $1.9 million in Q2 2014, from $1.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $2.9 million in Q3 2012 to a low of $1.8 million in Q4 2013.
• A 3-year average of $2.1 million and a median of $1.9 million in 2014 frame the typical range for Total Non-Current Liabilities.
• Peak annual rise in Total Non-Current Liabilities reached 32.39% in 2013, while the deepest fall reached 32.39% in 2013.
• Tracing AVXL's Total Non-Current Liabilities over 3 years: stood at $2.9 million in 2012, then sank by 36.95% to $1.8 million in 2013, then increased by 4.62% to $1.9 million in 2014.
• Business Quant data shows AVXL's Total Non-Current Liabilities at $1.9 million in Q2 2014, $1.9 million in Q1 2014, and $1.8 million in Q4 2013.